NCT07504913 Spanish Validation of KOQUSS-40 Questionnaire: Assessing QoL of Gastric Cancer Patients After Gastrectomy: SPQUSS-41
| NCT ID | NCT07504913 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Parc de Salut Mar |
| Condition | Stomach Neoplasms |
| Study Type | OBSERVATIONAL |
| Enrollment | 505 participants |
| Start Date | 2025-05-03 |
| Primary Completion | 2026-10-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 505 participants in total. It began in 2025-05-03 with a primary completion date of 2026-10-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The main objective of this study is the translation, linguistic adaptation into Spanish, and validation of the Korean quality of life questionnaire KOQUSS-40. This tool will allow us to objectively measure the quality of life of patients in clinical trials.
Eligibility Criteria
Inclusion Criteria: * Patients operated on for gastric cancer with curative intent from 1 month postoperatively up to the last 5 years * Adult patients over 18 years old * No recurrence of the disease * Patients who have given their informed consent to participate in the Spanish EURECCA Registry of Esophagogastric Cancer and have signed the specific consent for the SPQUSS-4 study Exclusion Criteria: * First 30 days after surgery and/or patients with postoperative complications requiring more than 30 days of hospitalization. * Patients who do not give their consent to participate in the study will be excluded. * Patients with a history of other neoplasms. * Patients with disseminated gastric cancer or candidates for palliative surgery, as well as those patients who do not give their consent to participate.
Contact & Investigator
Manuel Pera, PhD
STUDY DIRECTOR
Hospital del Mar de Barcelona
Frequently Asked Questions
Who can join the NCT07504913 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Stomach Neoplasms. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07504913 currently recruiting?
Yes, NCT07504913 is actively recruiting participants. Contact the research team at eurecca.geeceg@gmail.com for enrollment information.
Where is the NCT07504913 trial being conducted?
This trial is being conducted at Badalona, Spain, Barcelona, Spain, L'Hospitalet de Llobregat, Spain, Puerto Real, Spain and 2 additional locations.
Who is sponsoring the NCT07504913 clinical trial?
NCT07504913 is sponsored by Parc de Salut Mar. The principal investigator is Manuel Pera, PhD at Hospital del Mar de Barcelona. The trial plans to enroll 505 participants.